Anti-Cardiac Ryanodine Receptor Antibodies in Thymoma-Associated Myasthenia Gravis

References

• Lindström J. Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome. Ann Rev Immunol 1985; 3: 109–131
   PubMed Web of Science ®Google Scholar
• Namba T, Brunner NG, Grob D. Association of myasthenia gravis with pemphigus vulgaris, Candida albicans infection, polymyositis and myocarditis. J Neurol Sci 1973; 20: 231–242
   PubMed Web of Science ®Google Scholar
• Rowland LP, Hoefer PFA, Aranow H, Merrit HH. Fatalities in myasthenia gravis. Neurology 1956; 6: 307–326
   PubMed Web of Science ®Google Scholar
• Hofstad H, Ohm O-J, Mørk SJ, Aarli JA. Heart disease in myasthenia gravis. Acta Neurol Scand 1984; 70: 176–184
   PubMed Web of Science ®Google Scholar
• de Jongste MJL, Oosterhuis HJGH, Lie KI. Intractable ventricular tachycardia in a patient with giant cell myocarditis, thymoma and myasthenia gravis. Int J Cardiol 1986; 13: 374–378
   PubMed Web of Science ®Google Scholar
• Williams CL, Lennon VA. Thymic B-lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, ct-actinin or actin. J Exp Med 1986; 164: 1043–1059
   PubMed Web of Science ®Google Scholar
• Aarli JA, Stefansson K, Marton LSG, Wollmann RL. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin Exp Immunol 1990; 82: 284–288
   PubMed Web of Science ®Google Scholar
• Ohta M, Ohta K, Itoh N. Anti-skeletal muscle antibodies in the sera from myasthenic patients with thymoma: identification of anti-myosin, actomyosin, actin, and a-actinin antibodies by a solid-phase radioimmunoassay and a Western blotting analysis. Clin Chim Acta 1990; 187: 255–264
   PubMed Web of Science ®Google Scholar
• Williams CL, Hay JE, Huiatt TW, Lennon VA. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in sera of patients with myasthenia gravis and thymoma react with titin. Lab Invest 1992; 66: 331–336
   PubMed Web of Science ®Google Scholar
• Mygland Å., Tysncs O-B., Matre R, Volpe P, Aarli J A, Gilhus NE. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Ann Neurol 1992; 32: 589–591
   PubMed Web of Science ®Google Scholar
• Mygiand Å., Tysnes O-B., Aarli JA, Flood PR, Gilhus NE. Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmic reticulum. J Neuroimmunol 1992; 37: 1–7
   PubMed Web of Science ®Google Scholar
• Takeshima H, Nishimura S, Matsumoto T, Ishida H, Kan-Gawa K, Minamino N, Matsuo H, Ueda M, Hanaoka M, Hirose T, Numa S. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 1989; 339: 439–445
   PubMed Web of Science ®Google Scholar
• Lai FA, Erickson HP, Rousseau E, Liu Q-Y, Meissner G. Purification and reconstitution of the calcium release channel. Nature 1988; 331: 315–319
   PubMed Web of Science ®Google Scholar
• Lai FA, Meissner G. Structure of the calcium release channel of skeletal muscle sarcoplasmic reticulum and its regulation by calcium. Adv Exp Med Biol 1990; 269: 73–77
   PubMedGoogle Scholar
• Otsu K, Willard HF, Khanna VK, Zorzato F, Green NM, MacLennan DH. Molecular clonong of cDNA encoding the Ca2 + release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J Biol Chem 1990; 265: 13472–13483
   PubMed Web of Science ®Google Scholar
• Inui M, Saito A, Fleischer S. Isolation of the ryanodine receptor from cardiac sarcoplasmic reticulum and identity with the feet structures. J Biol Chem 1987; 262: 15637–15642
   PubMed Web of Science ®Google Scholar
• Anderson K, Lai FA, Liu Q-Y, Rousseau E, Erickson HP, Meissner G. Structural and functional characterization of the purified cardiac ryanodine receptor-Ca2 + release channel complex. J Biol Chem 1989; 264: 1329–1335
   PubMed Web of Science ®Google Scholar
• Imagawa T, Takasago T, Shigekawa M. Cardiac ryanodine receptor is absent in type 1 slow skeletal muscle fibers: immunochemical and ryanodine binding studies. J Biochem 1989; 106: 342–348
   PubMed Web of Science ®Google Scholar
• Knudson CM, Caudhari N, Sharp AH, Powell JA, Beam KG, Campbell KP. Specific absence of the a, subunit of the dihydropyridine receptor in mice with muscular dysgenesis. J Biol Chem 1989; 264: 1345–1348
   PubMed Web of Science ®Google Scholar
• Kuwajima G, Futatsugi A, Niinobe M, Nakanishi S, Miko-Shiba K. Two types of yanodine receptors in mouse brain: skeletal muscle type exclusively in purkinje cells and cardiac muscle type in various types. Neuron 1992; 9: 1133–1142
   PubMed Web of Science ®Google Scholar
• Jones LR, Besch HR, Jr, Fleming JW, McConnaughey MM, Watanabe AM. Separation of vesicles of cardiac sarcolemma from vesicles of cardiac sarcoplasmic reticulum: comparative biochemical analysis of component activities. J Biol Chem 1979; 254: 530–539
   PubMed Web of Science ®Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• Towbin H, Stahelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350–4354
   PubMed Web of Science ®Google Scholar
• Harcourt G. C., Sommer N., Rothbard J., WiUcox H. N.A., Newsom-Davis J. A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis. J. Clin Invest 1988; 82: 1295–1300
   PubMed Web of Science ®Google Scholar
• Sommer N. N. Willcox, G.C. Harcourt, and J. Newsom-Davis. Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells. Ann Neurol 1990; 28: 312–319
   PubMed Web of Science ®Google Scholar
• Protti MP, Manfredi AA, Horton RM, Bellone M, Conte-Tronconi. Myasthenia gravis: recognition of a human auto-antigen at the molecular level. Immunol Today 1993; 14: 363–368
   PubMedGoogle Scholar
• Gilhus NE, Aarli JA, Christensson B, Matre R. Rabbit antiserum to a citric acid extract of human skeletal muscle staining thymomas from myasthenia gravis patients. J Neuroimmunol 1984; 7: 55–64
   PubMed Web of Science ®Google Scholar
• Marx A, O'Connor R, Geuder KI, Hoppe F, Schalke B, Tzartos S, Kalies I, Kirchner T, Müller Hermelink HK. Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis associated thymomas. Lab Invest 1990; 62: 279–286
   PubMed Web of Science ®Google Scholar
• Dardenne M, Savino W, Bach JF. Thymomatous epithelial cells and skeletal muscle share a common epitope defined by a monoclonal antibody. Am J Pathol 1987; 126: 194–198
   PubMed Web of Science ®Google Scholar
• Oosterhuis HJGH. The natural course of mysthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiat 1989; 52: 1121–27
   PubMed Web of Science ®Google Scholar
• Namba T, Brunner NG, Grob D. Association of myasthenia gravis with pemphigus vulgaris, Candida albicans infection, polimyositis and myocarditis. J Neurol Sci 1973; 20: 231–242
   PubMed Web of Science ®Google Scholar
• Mygiand A, Aarli JA, Matre R, Gilhus NE. Anti-ryanodine receptor antibodies related to severity of thymoma-associated myasthenia gravis. J Neurol Neurosurg Psychiat 1994, In press
   Web of Science ®Google Scholar